{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:27:02Z","timestamp":1758040022542,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013961","name":"Robertson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ahj.2021.08.007","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T19:27:32Z","timestamp":1631129252000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9187-7681","authenticated-orcid":false,"given":"Nikola","family":"Pavlovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian-Battista","family":"Chierchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-5840","authenticated-orcid":false,"given":"Vedran","family":"Velagic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Sylvain","family":"Hermida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stewart","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-6493","authenticated-orcid":false,"given":"Giuseppe","family":"Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Badenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0217-3960","authenticated-orcid":false,"given":"Christian","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-5706","authenticated-orcid":false,"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Iacopino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Anselme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1623-0535","authenticated-orcid":false,"given":"Fernando","family":"Scazzuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L","family":"Packer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"de Asmundis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Friedrich","family":"Pitschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-4156","authenticated-orcid":false,"given":"Fabio Di","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-8956","authenticated-orcid":false,"given":"Rachelle E","family":"Kaplon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1593-9657","authenticated-orcid":false,"given":"Malte","family":"Kuniss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2021.08.007_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2021.08.007_bib0002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2021.08.007_bib0003","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2021.08.007_bib0004","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/jce.14000","article-title":"Diagnosis-to-ablation time in atrial fibrillation: a modifiable factor relevant to clinical outcome","volume":"30","author":"Bisbal","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.hrthm.2013.05.013","article-title":"Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes","volume":"10","author":"Bunch","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2021.08.007_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008128","article-title":"Diagnosis-to-ablation time and recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis of observational studies","volume":"13","author":"Chew","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2019.03.036","article-title":"Early choice for catheter ablation reduced readmission in management of atrial fibrillation: impact of diagnosis-to-ablation time","volume":"291","author":"Kawaji","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.08.007_bib0009","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/europace\/euu376","article-title":"Radiofrequency ablation vs antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis","volume":"17","author":"Hakalahti","year":"2015","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ahj.2021.08.007_bib0010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2021.08.007_bib0011","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.08.007_bib0012","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2021.08.007_bib0013","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.08.007_bib0014","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.08.007_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ahj.2019.12.006","article-title":"Cryoballoon catheter ablation vs antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: rationale and design of the international Cryo-FIRST study","volume":"222","author":"Hermida","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.08.007_bib0016","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2021.08.007_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005358","article-title":"Defining clinically important difference in the atrial fibrillation effect on quality-of-life score","volume":"12","author":"Holmes","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2021.08.007_bib0018","unstructured":"Maruish ME. User's manual for the SF-36v2 Health Survey (3rd ed.). Lincoln, RI: QualityMetric Incorporated. 2011."},{"key":"10.1016\/j.ahj.2021.08.007_bib0019","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacep.2020.04.017","article-title":"Quality of life and health care utilization in the CIRCA-DOSE study","volume":"6","author":"Andrade","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0020","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.hrthm.2020.06.020","article-title":"Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: results from the multicenter STOP persistent AF trial","volume":"17","author":"Su","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ahj.2021.08.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6590358","article-title":"Patients' experiences of living with atrial fibrillation: a mixed methods study","volume":"2019","author":"Stridsman","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.ahj.2021.08.007_bib0022","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstrom-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2021.08.007_bib0023","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacep.2018.07.007","article-title":"Single-procedure outcomes and quality-of-life improvement 12 months post-cryoballoon ablation in persistent atrial fibrillation: results from the multicenter CRYO4PERSISTENT AF Trial","volume":"4","author":"Boveda","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0024","article-title":"Radiofrequency catheter ablation improves the quality of life measured with a short form-36 questionnaire in atrial fibrillation patients: a systematic review and meta-analysis","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2021.08.007_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/europace\/eut369","article-title":"Quality of life in patients with atrial fibrillation: how to assess it and how to improve it","volume":"16","author":"Aliot","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2021.08.007_bib0026","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1540-8167.2007.01091.x","article-title":"Quality of life in atrial fibrillation: measurement tools and impact of interventions","volume":"19","author":"Reynolds","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire in patients with atrial fibrillation","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ahj.2021.08.007_bib0028","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ahj.2014.02.003","article-title":"Drivers of hospitalization for patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"167","author":"Steinberg","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2021.08.007_bib0029","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870321002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:07:28Z","timestamp":1757570848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870321002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"alternative-id":["S0002870321002052"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2021.08.007","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2021.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}